Retrospective database study using PearlDiver (Medicare 2005–2014, Humana 2007–2014) analyzing over 1.1 million distal radius fracture treatment claims. Characterizes age- and gender-specific epidemiology, shifts in treatment modality over a decade, and complication rates by treatment type across four age groups.
The AAOS guidelines provide moderate-strength thresholds for surgery (radial shortening >3 mm, dorsal tilt >10°, intra-articular step-off >2 mm), but none of the 29 recommendations were graded as strong — leaving surgeons without clear guidance, which this paper argues is a key driver of the ORIF surge.
When you see a distal radius fracture in a patient over 65, recognize that ORIF use in this group more than doubled over the study decade, yet the best available comparative data show no functional benefit over casting in low-demand elderly patients. The decision requires honest weighing of fracture instability, patient activity level, and implant cost against a documented higher complication rate with operative treatment.
For every complication except malunion, operative treatment carries statistically higher rates. Including a threefold higher risk of tendon rupture. Malunion risk is real with casting, but comparative studies confirm it does not reliably translate to worse functional outcomes in elderly patients.
In pediatric patients, the data confirm that closed treatment and percutaneous pinning dominate and have remained stable. ORIF rates held flat at 1.1–1.3% throughout the decade, reflecting appropriate restraint in a population with robust healing potential.
Retrospective database study using PearlDiver (Medicare 2005–2014, Humana 2007–2014) analyzing over 1.1 million distal radius fracture treatment claims. Characterizes age- and gender-specific epidemiology, shifts in treatment modality over a decade, and complication rates by treatment type across four age groups.
The AAOS guidelines provide moderate-strength thresholds for surgery (radial shortening >3 mm, dorsal tilt >10°, intra-articular step-off >2 mm), but none of the 29 recommendations were graded as strong — leaving surgeons without clear guidance, which this paper argues is a key driver of the ORIF surge.
When you see a distal radius fracture in a patient over 65, recognize that ORIF use in this group more than doubled over the study decade, yet the best available comparative data show no functional benefit over casting in low-demand elderly patients. The decision requires honest weighing of fracture instability, patient activity level, and implant cost against a documented higher complication rate with operative treatment.
For every complication except malunion, operative treatment carries statistically higher rates. Including a threefold higher risk of tendon rupture. Malunion risk is real with casting, but comparative studies confirm it does not reliably translate to worse functional outcomes in elderly patients.
In pediatric patients, the data confirm that closed treatment and percutaneous pinning dominate and have remained stable. ORIF rates held flat at 1.1–1.3% throughout the decade, reflecting appropriate restraint in a population with robust healing potential.